MENU

PHAT Phathom Pharmaceuticals Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology
PHAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
PHAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PHAT is expected to report earnings to fall 5.77% to -147 cents per share on November 06

Phathom Pharmaceuticals PHAT Stock Earnings Reports
Q3'24
Est.
$-1.47
Q2'24
Missed
by $0.24
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.27
Q3'23
Beat
by $0.13
The last earnings report on August 08 showed earnings per share of -155 cents, missing the estimate of -132 cents. With 961.08K shares outstanding, the current market capitalization sits at 1.20B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
452
Web
https://www.phathompharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

PHAT and Stocks

Correlation & Price change

A.I.dvisor tells us that PHAT and OCGN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHAT and OCGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-1.69%
OCGN - PHAT
31%
Poorly correlated
-6.92%
OCUL - PHAT
30%
Poorly correlated
-5.33%
ERAS - PHAT
29%
Poorly correlated
-5.19%
ANNX - PHAT
29%
Poorly correlated
-5.09%
TERN - PHAT
29%
Poorly correlated
-5.12%
More